{"ticker":"RUA","name":"Rua Bioscience Limited","slug":"rua-bioscience","sector":"Healthcare","industry":null,"exchange":"NZX","exchange_mic":"XNZE","isin":"NZRUAE0004S1","lei":null,"permid":null,"website_url":"https://ruabio.com","description":"Rua Bioscience is a Maori-owned medicinal cannabis company cultivating, manufacturing, and exporting pharmaceutical-grade cannabis products from Gisborne.","financial_year_end":"June","as_of":"2026-06-13","generated_at":"2026-06-13T19:11:57.251Z","canonical_url":"https://nzxplorer.co.nz/companies/rua-bioscience","data_license":"CC BY 4.0 with attribution to NZXplorer + NZX as primary disclosure source","market":{"as_of":"2026-06-12","market_cap_nzd":11155376,"last_close_nzd":0.03,"last_close_date":"2026-06-12","currency":"NZD"},"governance":{"as_of":"2026-06-11T16:03:20.852+00:00","grs":75.17,"grs_rating":"Very Good","grs_calculated_at":"2026-06-11T16:03:20.852+00:00","board_structure_score":18,"exec_remuneration_score":5,"board_size":5,"independent_directors":2,"board_independence_pct":40,"chair_name":"Anna Stove","chair_slug":"anna-stove","ceo_name":"Paul Naske","ceo_role_label":"Chief Executive Officer","board":[{"name":"Anna Stove","slug":"anna-stove","profile_url":"https://nzxplorer.co.nz/people/anna-stove","is_chair":true,"is_independent":false},{"name":"Antony (Tony) George Barclay","slug":"antony-tony-george-barclay","profile_url":"https://nzxplorer.co.nz/people/antony-tony-george-barclay","is_chair":false,"is_independent":true},{"name":"Panapa  Ehau","slug":"panapa-ehau","profile_url":"https://nzxplorer.co.nz/people/panapa-ehau","is_chair":false,"is_independent":false},{"name":"Paul Naske","slug":"paul-naske","profile_url":"https://nzxplorer.co.nz/people/paul-naske","is_chair":false,"is_independent":false},{"name":"Teresa Ciprian","slug":"teresa-ciprian","profile_url":"https://nzxplorer.co.nz/people/teresa-ciprian","is_chair":false,"is_independent":true}]},"financials_latest_fy":{"as_of":"FY2025","fiscal_year":2025,"currency":"NZD","units":"thousands","revenue_thousands":2,"gross_profit_thousands":null,"ebitda_thousands":null,"ebit_thousands":-3500000,"net_profit_thousands":-3500000,"eps_cents":-1035.38,"dividends_per_share_cents":null,"total_assets_thousands":6781605,"total_equity_thousands":4890712,"net_debt_thousands":null,"cash_and_equivalents_thousands":null,"total_borrowings_thousands":null,"operating_cash_flow_thousands":-2800000,"free_cash_flow_thousands":-2803430,"capex_thousands":3430000},"ratios_latest_fy":{"as_of":"FY2025","fiscal_year":2025,"gross_margin":null,"net_margin":null,"ebitda_margin":null,"roe":-71.56,"roa":-51.61,"debt_to_equity":0.39,"current_ratio":null},"dividends_latest":null,"latest_announcement":{"as_of":"2026-05-22","id":68270,"date":"2026-05-22","title":"Ongoing Disclosure Notice - Paul Naske","type":"SHINTR","url":"https://www.nzx.com/announcements/473199"},"recent_changes":[{"date":"2026-06-11","facet":"governance","change":"Governance Risk Score recalculated: 75.17 (Very Good)"}],"links":{"page":"https://nzxplorer.co.nz/companies/rua-bioscience","detail_json":"https://nzxplorer.co.nz/api/v1/companies/RUA?include=all","facts_json":"https://nzxplorer.co.nz/api/v1/companies/RUA/facts.json","nzx":"https://www.nzx.com/companies/RUA"}}